Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
Per Dr. ___ has class III morbid obesity with 
weight of 341.5 pounds as of ___, with his initial screen 
weight of 365.8 pounds on ___, height of 71 inches and BMI 
of 47.6.  His previous weight loss efforts have included Weight 
Watchers, the ___ and ___ diets, Slim-Fast and ___ 
___ losing up to 50 pounds but his weight loss attempts at 
failed to produce lasting results.  He has not taken 
prescription weight loss medications or used over-the-counter 
ephedra-containing appetite suppressants/herbal supplements.  He 
stated that he has been struggling with weight his whole life 
and cites as factors contributing to his excess weight he 
genetics, too many saturated fats, large portions, grazing, 
late-night eating, convenience eating and lack of exercise.  He 
does walk every morning for ___ minutes that he has been doing 
for the past couple of months.  He denied history of eating 
disorders and denied binge eating.  He does have 
depression/anxiety with history of panic attacks but has not 
been seen by a therapist nor has he been hospitalized for mental 
health issues and he is on psychotropic medications (sertraline, 
clonazepam and trazodone).

 
Past Medical History:
1)  hyperlipidemia
2)  vitamin D deficiency
3)  hepatic steatosis by ultrasound study.

His surgical history is noted for tympanostomy x 2 in ___ and
___ at the ages of 2 and ___.

 
Social History:
___
Family History:
He does have a family history of obesity with his father who had 
a Roux-en-Y gastric bypass in ___ or ___ that was complicated 
by ulcer secondary to NSAIDs usage; sister living with obesity 
s/p laparoscopic adjustable gastric band in ___.
 
Physical Exam:
VS: T 98.5 P 94 BP 129/85 RR 18 02 95%RA
Gen: no acute distress
Cardiac: regular rate and rhythm, no murmurs appreciated
Respiratory: clear to auscultation, bilaterally
Abdomen: soft, appropriate ___ tenderness without 
rebound tenderness or guarding
Wounds: abdominal lap sites with steri-strips, CDI; no periwound 
erythema, induration or drainage
 
Pertinent Results:
___ 04:50AM BLOOD Hct-44.9
___ 09:37AM BLOOD Hct-45.7
 
Brief Hospital Course:
The patient presented to pre-op on ___. Pt was 
evaluated by anaesthesia and taken to the operating room where 
he underwent a laparoscopic sleeve gastrectomy. There were no 
adverse events in the operating room; please see the operative 
note for details. Pt was extubated, taken to the PACU until 
stable, then transferred to the ward for observation. 

Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA and 
intravenous acetaminophen and then transitioned to oral 
oxycodone and acetaminophen once tolerating a stage 2 diet. 
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.
Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization. 
GI/GU/FEN: The patient was initially kept NPO.  A methylene blue 
dye test (performed intra-operatively was negative for a leak, 
therefore, the diet was advanced sequentially to a Bariatric 
Stage 3 diet, which was well tolerated. Patient's intake and 
output were closely monitored.  
ID: The patient's fever curves were closely watched for signs of 
infection, of which there were none.
HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.
Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.

At the time of discharge, the patient was doing well, afebrile 
with stable vital signs.  The patient was tolerating a stage 3 
diet, ambulating, voiding without assistance, and pain was well 
controlled.  The patient received discharge teaching and 
follow-up instructions with understanding verbalized and 
agreement with the discharge plan.

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. ClonazePAM 0.5 mg PO ASDIR 
2. Sertraline 50 mg PO DAILY 
3. Sertraline 25 mg PO DAILY 
4. TraZODone 25 mg PO QHS:PRN insomnia 
5. Vitamin D ___ UNIT PO 2X/WEEK (___) 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Mild 
RX *acetaminophen 650 mg/20.3 mL 20 ml by mouth every six (6) 
hours Refills:*0 
2.  Docusate Sodium 100 mg PO BID:PRN constipation 
RX *docusate sodium 50 mg/5 mL 10 ml by mouth twice a day 
Refills:*0 
3.  OxycoDONE Liquid ___ mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL ___ mg by mouth every four (4) hours 
Refills:*0 
4.  Ranitidine (Liquid) 150 mg PO BID 
RX *ranitidine HCl 15 mg/mL 10 ml by mouth twice a day 
Refills:*0 
5.  Sertraline 75 mg PO DAILY  
6.  Sertraline 25 mg PO DAILY  
7.  Vitamin D ___ UNIT PO 2X/WEEK (___)  
8. HELD- ClonazePAM 0.5 mg PO ASDIR  This medication was held. 
Do not restart ClonazePAM until you are no longer taking 
oxycodone.
9. HELD- TraZODone 25 mg PO QHS:PRN insomnia  This medication 
was held. Do not restart TraZODone until you are no longer 
taking oxycodone.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Discharge Instructions: Please call your surgeon or return to 
the emergency department if you develop a fever greater than 
101.5, chest pain, shortness of breath, severe abdominal pain, 
pain unrelieved by your pain medication, severe nausea or 
vomiting, severe abdominal bloating, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness 
or swelling around your incisions, or any other symptoms which 
are concerning to you.

Diet: Stay on Stage III diet until your follow up appointment. 
Do not self advance diet, do not drink out of a straw or chew 
gum.

Medication Instructions:
Resume your home medications, CRUSH ALL PILLS.
You will be starting some new medications:
1.  You are being discharged on medications to treat the pain 
from your operation. These medications will make you drowsy and 
impair your ability to drive a motor vehicle or operate 
machinery safely. You MUST refrain from such activities while 
taking these medications.
2. You should begin taking a chewable complete multivitamin with 
minerals. No gummy vitamins.
3. You will be taking Zantac liquid ___ mg twice daily for one 
month. This medicine prevents gastric reflux.
4. You should take a stool softener, Colace, twice daily for 
constipation as needed, or until you resume a normal bowel 
pattern.
5. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs) Examples are Ibuprofen, Motrin, Aleve, Nuprin and 
Naproxen. These agents will cause bleeding and ulcers in your 
digestive system.

Activity:
No heavy lifting of items ___ pounds for 6 weeks. You may 
resume moderate exercise at your discretion, no abdominal 
exercises.

Wound Care:
You may shower, no tub baths or swimming. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Your steri-strips will fall off on their own. Please remove any 
remaining strips ___ days after surgery.
Please call the doctor if you have increased pain, swelling, 
redness, or drainage from the incision sites. 

 
Followup Instructions:
___